HELE vs VRTX · rev $1.79B vs P/E 30, rev $3.33B
Helen of Troy Ltd (HELE) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Helen of Troy Ltd (HELE) is a household & personal products company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported HELE revenue for 2026-02-28 was $1.79B. Net income was -$899.0M. Revenue was down 6.4% from 2025-02-28 to 2026-02-28. HELE currently screens at market cap $566.1M.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
HELE currently screens at market cap $566.1M. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the HELE and VRTX stock pages for the full models.
Not investment advice.